[go: up one dir, main page]

SI2916823T1 - Co-micronisation product comprising a progesterone receptor selective modulator - Google Patents

Co-micronisation product comprising a progesterone receptor selective modulator

Info

Publication number
SI2916823T1
SI2916823T1 SI201330642T SI201330642T SI2916823T1 SI 2916823 T1 SI2916823 T1 SI 2916823T1 SI 201330642 T SI201330642 T SI 201330642T SI 201330642 T SI201330642 T SI 201330642T SI 2916823 T1 SI2916823 T1 SI 2916823T1
Authority
SI
Slovenia
Prior art keywords
progesterone receptor
receptor selective
selective modulator
micronisation
product
Prior art date
Application number
SI201330642T
Other languages
Slovenian (sl)
Inventor
Florian Battung
Pierre-Yves Juvin
Jerome Hecq
Aude Colin
Original Assignee
Laboratoire Hra Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Hra Pharma filed Critical Laboratoire Hra Pharma
Publication of SI2916823T1 publication Critical patent/SI2916823T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201330642T 2012-11-08 2013-11-07 Co-micronisation product comprising a progesterone receptor selective modulator SI2916823T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1260605A FR2997628B1 (en) 2012-11-08 2012-11-08 CO-MICRONIZATION PRODUCT COMPRISING A SELECTIVE MODULATOR OF PROGESTERONE RECEPTORS
PCT/FR2013/052671 WO2014072647A1 (en) 2012-11-08 2013-11-07 Co-micronisation product comprising a selective progesterone-receptor modulator
EP13801640.7A EP2916823B1 (en) 2012-11-08 2013-11-07 Co-micronisation product comprising a progesterone receptor selective modulator

Publications (1)

Publication Number Publication Date
SI2916823T1 true SI2916823T1 (en) 2017-08-31

Family

ID=47714259

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201330642T SI2916823T1 (en) 2012-11-08 2013-11-07 Co-micronisation product comprising a progesterone receptor selective modulator

Country Status (22)

Country Link
US (1) US20150258118A1 (en)
EP (1) EP2916823B1 (en)
JP (1) JP2015536969A (en)
CN (1) CN105073098B (en)
CR (1) CR20150298A (en)
CY (1) CY1118884T1 (en)
DK (1) DK2916823T3 (en)
EA (1) EA029643B1 (en)
EC (1) ECSP15022505A (en)
ES (1) ES2625012T3 (en)
FR (1) FR2997628B1 (en)
GE (1) GEP201706648B (en)
HR (1) HRP20170686T1 (en)
LT (1) LT2916823T (en)
MD (1) MD4546C1 (en)
PL (1) PL2916823T3 (en)
PT (1) PT2916823T (en)
RS (1) RS55956B1 (en)
SI (1) SI2916823T1 (en)
SM (1) SMT201700237T1 (en)
UA (1) UA115573C2 (en)
WO (1) WO2014072647A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106265533A (en) * 2016-10-10 2017-01-04 朱隆娅 A kind of Adprin granule and preparation method thereof
FR3060389B1 (en) * 2016-12-20 2019-05-31 Laboratoire Hra-Pharma ENROBE COMPRISING COMPRISING ULIPRISTAL ACETATE OR ONE OF ITS METABOLITES
EP3895691A1 (en) 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Ulipristal acetate otf
WO2023033900A1 (en) 2021-09-06 2023-03-09 Slayback Pharma Llc Pharmaceutical compositions of mifepristone

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
JP2004099442A (en) * 2002-09-04 2004-04-02 Nisshin Pharma Inc Poorly soluble drug-containing preparation and method for producing the same
ES2212912B1 (en) 2003-01-22 2005-10-01 Crystal Pharma, S.A. PROCEDURE FOR OBTAINING 17ALFA-ACETOXI-11BETA- (4-N, N-DIMETHYLAMINEPHENYL) -19-NORPREGNA-4,9-DIEN-3,20-DIONA.
AU2005265357B2 (en) 2004-07-09 2011-04-07 Laboratoire Hra Pharma Sustained release compositions containing progesterone receptor modulators
BRPI0717747A2 (en) * 2006-10-24 2013-10-22 Repros Therapeutics Inc ENDOMETRIAL PROLIFERATION SUPPRESSION COMPOSITIONS AND METHODS
TW200831110A (en) * 2006-12-28 2008-08-01 Repros Therapeutics Inc Methods and formulations for improved bioavailability of antiprogestins
JP2008169135A (en) * 2007-01-11 2008-07-24 Takada Seiyaku Kk Method for producing glimepiride composition
US8299050B2 (en) * 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
TWI539953B (en) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 Compositions and methods for treating breast cancer
US8512745B2 (en) * 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
JP5951480B2 (en) 2009-04-14 2016-07-13 ラボラトワール・アシュエールア−ファルマＬａｂｏｒａｔｏｉｒｅ Ｈｒａ−Ｐｈａｒｍａ On-demand contraceptive methods
EP2535114A4 (en) * 2009-11-13 2015-11-18 Moriroku Chemicals Company Ltd Fine powder manufacturing method and fine powder manufactured using same
FR2988610B1 (en) * 2012-03-30 2014-10-31 Effik PROGESTATIVE CO-MICRONIZED WITH A POLYMER CARRYING THE PYRROLIDONE GROUP, COMPOSITION AND USES
CN102871977A (en) * 2012-10-19 2013-01-16 北京紫竹药业有限公司 Ulipristal acetate dispersible tablet and preparation method thereof

Also Published As

Publication number Publication date
RS55956B1 (en) 2017-09-29
MD4546C1 (en) 2019-03-31
ECSP15022505A (en) 2016-01-29
CR20150298A (en) 2015-08-14
PL2916823T3 (en) 2017-08-31
SMT201700237T1 (en) 2017-07-18
EP2916823A1 (en) 2015-09-16
MD4546B9 (en) 2018-08-31
EA201500514A1 (en) 2015-09-30
MD20150054A2 (en) 2015-10-31
GEP201706648B (en) 2017-03-27
DK2916823T3 (en) 2017-05-15
WO2014072647A1 (en) 2014-05-15
CN105073098B (en) 2019-02-19
PT2916823T (en) 2017-05-22
CN105073098A (en) 2015-11-18
CY1118884T1 (en) 2018-01-10
JP2015536969A (en) 2015-12-24
MD4546B1 (en) 2018-01-31
UA115573C2 (en) 2017-11-27
EP2916823B1 (en) 2017-02-15
ES2625012T3 (en) 2017-07-18
FR2997628A1 (en) 2014-05-09
HRP20170686T1 (en) 2017-09-08
EA029643B1 (en) 2018-04-30
US20150258118A1 (en) 2015-09-17
FR2997628B1 (en) 2015-01-16
LT2916823T (en) 2017-07-25

Similar Documents

Publication Publication Date Title
AP3338A (en) Glucagon receptor modulator
EP2838803A4 (en) Packaging system
EP2825934A4 (en) A tactile apparatus link
HK1212558A1 (en) Coupler for decorating bag
HK1208867A1 (en) Indolecarbonitriles as selective androgen receptor modulators
PL2936468T3 (en) Device for configuring a fire-detection system
HK1209744A1 (en) Novel selective androgen receptor modulators
AP2014007548A0 (en) Selective androgen receptor modulators
HK1214202A1 (en) Dispensing system
LT2916823T (en) Co-micronisation product comprising a progesterone receptor selective modulator
GB2498796B (en) Pill dispensing device
PL2890504T3 (en) Particulate dispensing apparatus
GB201220124D0 (en) A microfluid device
PL2917128T3 (en) Device for dosing creams
GB201223053D0 (en) Receptor
GB201218814D0 (en) A dosing device
GB201222485D0 (en) Product provisioning system
GB201203283D0 (en) Product provisioning system
GB201212127D0 (en) A stirring device
AU345610S (en) A carrying device
GB201207330D0 (en) Tablet dispensing device
GB201209642D0 (en) Dispensing system